BMS Allogenic Manufacturing Asset Life Cycle Activity
For Bristol Myers Squibb’s Allogenic Manufacturing Asset Life Cycle Activity project, CHA delivered a comprehensive reliability framework designed to safeguard high-value production. We moved beyond standard documentation to provide a rigorous, bottom-up enhancement of their maintenance ecosystem.
Our team conducted a deep-dive Asset Criticality Assessment and a specialized component-level review of BAS/QBAS systems, enabling the facility’s digital and physical infrastructure to remain in perfect alignment. By coordinating directly with vendors for spare parts and BOM development, we performed a critical spares analysis that eliminated potential single points of failure. The result was a seamless integration of verified data into the CMMS, providing BMS with a proactive, data-driven strategy for long-term operational resilience.
Project summary
Identification of 132 spare parts.
Asset criticality assessment of 51 items.
Integration of 333 CMS entries.
Talk to an expert
Denis Sichkar, PMP
Project Team Leader,
Senior Project Manager
Denis has eight years of experience in project management and various roles at a lean manufacturing facility. He has overseen numerous projects, verifying compliance with global pharmaceutical standards. Denis is adept at leading teams, promoting ongoing improvement, and applying standard project management practices.